Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes.

Cagent Vascular, Inc., the exclusive developer of serration technology for vessel dilation in endovascular interventions, ...

Teleflex management announced a significant acquisition and business split, but the market reacted negatively. Read why I remain neutral on TFX stock.

In 2006, Abbott acquired Guidant, a leader in coronary and vascular products, and Kos Pharmaceuticals, a speciality pharma company with a significant lipid management portfolio. In 2009 ...

and Abbott (NYSE: ABT). With a proven track record of driving revenue growth, expanding market share, and fostering strategic partnerships, he will play a critical role in scaling Cagent Vascular ...

The Vietnam baby food products market is projected to experience a steady growth rate, with a CAGR of 1.53% during the forecast period from 2025 to 2032. The market, valued at $1303.60 million in 2024 ...

Looking for ways to manage high cholesterol? A leading cardiologist and top dietitian say fried foods and meat aren't the ...

The global AI in Remote Patient Monitoring Market, valued at US$1551.8 million in 2023, is forecasted to grow at a robust ...

Stocks like India Pesticides, HFCL, NDR Auto Components, JSW Steel, GR Infraprojects, Biocon, Oil and Natural Gas Corporation ...